This panel of experienced deal makers and investors will discuss trends in M&A and shareholder activism in Life Sciences. The panel will examine the current market environment, the outlook for M&A and activism, how activists select potential investments, lessons learned from recent campaigns, advanced preparation, and best practices for engagement between companies and investors to maximize shareholder value. The panel will consist of leading BioPharma advisors and investors, including an investment banker, a lawyer, a communications strategist and a hedge fund investor.

Session ID: 327186